Taisho Pharma Hold Unsp- ADRTAIPY
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$12.07avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Taisho Pharma Hold Unsp- ADR (TAIPY) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($30K) and Hantz Financial Services, Inc. ($6K).
- Company
- Taisho Pharma Hold Unsp- ADR
- CUSIP
- 87402P105
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 407 shares sold, net −407 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | No change | 2,520 | $30K |
| Hantz Financial Services, Inc. | 0.00% | Reduce -45.8% | 482 | $6K |
"% of holder's portfolio" is TAIPY's weight in each manager's 13F, not the share of Taisho Pharma Hold Unsp- ADR the manager owns.